Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Mirabegron 50 MG
Placebo
Locations
1
United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Start Date
February 15, 2018
Primary Completion Date
December 15, 2019
Completion Date
December 15, 2019
Last Updated
March 24, 2021
NCT04641702
NCT06883175
NCT06213662
NCT07458555
NCT07451301
NCT07425977
Lead Sponsor
Thomas Jefferson University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions